Our campaign aimed to inform the wide public, the medical community and the pharmacists about the mucolytics and to remind ambroxol, to differentiate the mucolytics from antitussives and to finally to educate the wide public about ambroxol (Mucosolvan)
Our strategic approach was KOL’s relations program, detailing to HCPs (doctors and pharmacists), advertisements in trade and lay media , consensus meetings, participation in congresses and use all the tools of Press Office.
After 2 years we succeeded to inform both wide public and HCPs 100% resulting to be Mucosolvan of Boehringer-Ingelheim first in ranking.
